Christopher Bowden
2014
In 2014, Christopher Bowden earned a total compensation of $3.4M as Chief Medical Officer at Agios Pharmaceuticals.
Compensation breakdown
| Bonus | $120,000 |
|---|---|
| Non-Equity Incentive Plan | $135,577 |
| Option Awards | $2,917,823 |
| Salary | $251,432 |
| Other | $1,066 |
| Total | $3,425,898 |
Bowden received $2.9M in option awards, accounting for 85% of the total pay in 2014.
Bowden also received $120K in bonus, $135.6K in non-equity incentive plan, $251.4K in salary and $1.1K in other compensation.
Rankings
In 2014, Christopher Bowden's compensation ranked 2,559th out of 13,032 executives tracked by ExecPay. In other words, Bowden earned more than 80.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,559 out of 13,032 | 80th |
Division Manufacturing | 908 out of 4,965 | 82nd |
Major group Chemicals And Allied Products | 281 out of 1,690 | 83rd |
Industry group Drugs | 218 out of 1,369 | 84th |
Industry Pharmaceutical Preparations | 180 out of 1,042 | 83rd |
Source: SEC filing on April 24, 2017.
Bowden's colleagues
We found four more compensation records of executives who worked with Christopher Bowden at Agios Pharmaceuticals in 2014.
News
Agios Pharmaceuticals CEO Jacqualyn Fouse's 2021 pay slips 14% to $6.5M
April 28, 2022
Agios Pharmaceuticals CEO Jacqualyn Fouse's 2020 pay falls 54% to $7.6M
April 8, 2021
Agios Pharmaceuticals CEO Jacqualyn Fouse receives $17M in 2019
April 16, 2020
Agios Pharmaceuticals CEO David Schenkein's 2018 pay jumps 37% to $8.2M
April 18, 2019